Table 5.
Class of ncRNA | ncRNA | Cells/Tissue | Expression (up or down) in disease | Role | Detection method | Refs |
---|---|---|---|---|---|---|
lncRNA |
AL035425.3
PWAR6 |
Skin Biopsies | Down | Competing endogenous RNA, candidate regulator of a miR network associated with psoriasis | High-throughput sequencing data from Gene Expression Omnibus (GEO) | [184] |
AGXT2L1–2:2 | Keratinocytes | Up | Inhibits apoptosis and promotes proliferation of keratinocytes | qRT-PCR | [188] | |
CARD14
CYP4Z2P HINT1 RPSAP58 TRHDE-AS1 |
Skin Biopsies | Up | Biomarkers | RNAseq | [103] | |
lnc-RP11–701H24.7
lnc-RNU12 |
PBMCs | Up | Biomarkers | RNAseq | [187] | |
LUCAT1
TRIM55–1 LINC00657 LINC00909 |
PBMCs | Up | Decoded to interplay with immune response via pathway analysis | Microarray | [104] | |
MEG3 | Skin Biopsies | Down | Interacts with miR-21 to regulate caspase-8 levels, implicated in cell proliferation and apoptosis | qRT-PCR | [190] | |
NORAD | Keratinocytes | Up | Promotes proliferation of keratinocytes | qRT-PCR | [189] | |
PRINS | Keratinocytes | Down in inflammato ry cytokine treated cells | PRINS overexpression decreased IL-6 and IL-8 expression | qRT-PCR | [191] | |
PRINS | Plasma | Down | Biomarker | qRT-PCR | [192] | |
SPRR2C | Keratinocytes and psoriatic lesion | Up | Promotes Inflammation and cell viability, sponges miR-330 to enhance STAT1 and S1007 | RNAseq and qRT-PCR | [186] | |
XIST | Serum | Up | Biomarker and miR sponge for miR-338–5p, which targets IL6 mRNA for silencing | qRT-PCR | [193] | |
Many | Skin biopsies | Up and Down | 1214 lncRNAs up and down-regulated in lesional psoriasis | RNAseq | [183] | |
circRNA |
CDR1as
hsa_circ_0109327 hsa_skin_05227 |
Skin Biopsies | Down | Computationally predicted to act as competitive endogenous RNAs sponging cellular miRs | RNAseq | [206] |
circCAMSAP1
circTRIM35 circTULP4 circARAP2 ciRS-7/CDR1as |
Skin Biopsies | Down | Genome-wide profiling of circRNAs from paired lesional vs non-lesional skin | RNAseq NanoString CISH |
[195] | |
circEIF5 | Skin Biopsies | Up | Knockdown and overexpression in HaCaT cells inhibited and enhanced proliferation, respectively Activates NF-κB and STAT3 | qRT-PCR | [201] | |
circOAS3 | Skin Biopsies | Up | Interacting with Hsp70 and regulates signaling through the JNK MAPK, NF-κB and STAT3 pathways to enhance proliferation of keratinocytes | Microarray | [200] | |
circRAB3B | Skin Biopsies | Down | Downregulated by IL-22 (in HaCaT cells) Inhibits cell proliferation by sponging miR-1228–3p, which targets PTEN |
qRT-PCR | [198] | |
circRNA
chr2:206992521|206994966 |
Skin Biopsies | Down | Regulation of IL-11, IL-6 and hepatocyte growth factor in skin MSCs; regulation of co-cultured T cell proliferation | RNAseq | [203] | |
circTULP4
circPARD3 circPTPRA ciRS-7 |
Skin Biopsies | Down | Repressed circRNAs that normalized after treatment with anti-IL-17 | Targeted NanoString panel |
[197] | |
ciRS-7
circZRANB1 |
Skin Biopsies | Down Up |
Biomarkers of disease | RNAseq | [196] | |
hsa_circ_0003689
chr4:121675708|121732604 hsa_circ_0003718 |
Skin Biopsies Plasma | Up | Biomarkers | RNAseq | [204] | |
hsa_circ_0056856 | Serum samples | Up | Biomarker, predicted to function as a competitive endogenous RNA | Microarray qRT-PCR | [205] | |
hsa_circ_0061012 | Skin Biopsies | Up | miR sponge | Microarray | [199] | |
hsa_circ_0061012 | Skin Biopsies | Up | Upregulated in HaCaT cells by IL-22. Silencing reduced proliferation of HaCat cells. Upregulates GAB2 by Sponging miR-194–5p | qRT-PCR | [202] |